Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Y Graham

Showing results (291-300 of 481) with videos related to

Pageof 49
Sort By:
Helicobacter|May 22, 2019
High-dose PPI-amoxicillin dual therapy with or without bismuth for first-line Helicobacter pylori therapy: A randomized trialLou Yu, Laisheng Luo, Xiaohua Long, et al.
The Journal of Infectious Diseases|May 13, 2009
Evidence against Helicobacter pylori being related to childhood asthmaS Mahendar Raj, Keng Ee Choo, A Majid Noorizan, et al.
The Journal of Infectious Diseases|February 26, 2009
Evidence against Helicobacter pylori Being Related to Childhood AsthmaS Mahendra Raj, Keng Ee Choo, A Majid Noorizan, et al.
Digestive Diseases and Sciences|March 30, 2007
Failures in a proton pump inhibitor therapeutic substitution program: lessons learnedMaggie Lu, Vikram Malladi, Aamer Agha, et al.
Cancer Research|May 19, 2006
Balance between polyoma enhancing activator 3 and activator protein 1 regulates Helicobacter pylori-stimulated matrix metalloproteinase 1 expressionJeng Yih Wu, Hong Lu, Yubo Sun, et al.
The Journal of Infectious Diseases|January 14, 2011
Effects of blood group antigen-binding adhesin expression during Helicobacter pylori infection of Mongolian gerbilsTomoyuki Ohno, Anna Vallström, Massimo Rugge, et al.
Helicobacter|March 12, 2014
Feasibility of shortening 14-day hybrid therapy while maintaining an excellent Helicobacter pylori eradication rateJeng-Yih Wu, Ping-I Hsu, Deng-Chyang Wu, et al.
Annals of Internal Medicine|May 5, 2020
Rifabutin-Based Triple Therapy (RHB-105) for <i>Helicobacter pylori</i> Eradication: A Double-Blind, Randomized, Controlled TrialDavid Y Graham, Yamil Canaan, James Maher, et al.
Gastroenterology|February 23, 2022
Comparable Results of Helicobacter pylori Antibiotic Resistance Testing of Stools vs Gastric Biopsies Using Next-Generation SequencingSteven F Moss, Long P Dang, David Chua, et al.
Scandinavian Journal of Infectious Diseases|December 17, 2008
Prevalence of cagA in relation to clinical presentation of Helicobacter pylori infection in EgyptAbdallah Said Essa, Mohammed Alaa Eldeen Nouh, Naglaa Mohammed Ghaniam, et al.
Pageof 49

Showing results (291-300 of 481) with videos related to

Sort By:
Pageof 49
Helicobacter|May 22, 2019
High-dose PPI-amoxicillin dual therapy with or without bismuth for first-line Helicobacter pylori therapy: A randomized trialLou Yu, Laisheng Luo, Xiaohua Long, et al.
The Journal of Infectious Diseases|May 13, 2009
Evidence against Helicobacter pylori being related to childhood asthmaS Mahendar Raj, Keng Ee Choo, A Majid Noorizan, et al.
The Journal of Infectious Diseases|February 26, 2009
Evidence against Helicobacter pylori Being Related to Childhood AsthmaS Mahendra Raj, Keng Ee Choo, A Majid Noorizan, et al.
Digestive Diseases and Sciences|March 30, 2007
Failures in a proton pump inhibitor therapeutic substitution program: lessons learnedMaggie Lu, Vikram Malladi, Aamer Agha, et al.
Cancer Research|May 19, 2006
Balance between polyoma enhancing activator 3 and activator protein 1 regulates Helicobacter pylori-stimulated matrix metalloproteinase 1 expressionJeng Yih Wu, Hong Lu, Yubo Sun, et al.
The Journal of Infectious Diseases|January 14, 2011
Effects of blood group antigen-binding adhesin expression during Helicobacter pylori infection of Mongolian gerbilsTomoyuki Ohno, Anna Vallström, Massimo Rugge, et al.
Helicobacter|March 12, 2014
Feasibility of shortening 14-day hybrid therapy while maintaining an excellent Helicobacter pylori eradication rateJeng-Yih Wu, Ping-I Hsu, Deng-Chyang Wu, et al.
Annals of Internal Medicine|May 5, 2020
Rifabutin-Based Triple Therapy (RHB-105) for <i>Helicobacter pylori</i> Eradication: A Double-Blind, Randomized, Controlled TrialDavid Y Graham, Yamil Canaan, James Maher, et al.
Gastroenterology|February 23, 2022
Comparable Results of Helicobacter pylori Antibiotic Resistance Testing of Stools vs Gastric Biopsies Using Next-Generation SequencingSteven F Moss, Long P Dang, David Chua, et al.
Scandinavian Journal of Infectious Diseases|December 17, 2008
Prevalence of cagA in relation to clinical presentation of Helicobacter pylori infection in EgyptAbdallah Said Essa, Mohammed Alaa Eldeen Nouh, Naglaa Mohammed Ghaniam, et al.
Pageof 49